Suzanne Klutch
Nurse Practitioner · Pittsburgh, PANPI 1659850170
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $30,073 of the $34,767 with a category attached, or 86.5%. AbbVie accounts for 73.2% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $17,891 and has fallen 99.6% since, to $75 in 2024. Among nurse practitioner clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 360 payments — averaging $96.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$25K
- Biohaven Pharmaceutical Holding Company Ltd.$7K
- Biohaven Pharmaceuticals, Inc.$400
- Novo Nordisk$340
- Teva Pharmaceuticals USA, Inc.$332
- Amgen$281
- plus $858 from 15 others
What the payments were for
- Speaking & faculty fees$30,07386%
- Food & beverage$4,68713%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 159 | $25,442 |
| Biohaven Pharmaceutical Holding Company Ltd. | 50 | $7,113 |
| Biohaven Pharmaceuticals, Inc. | 28 | $400 |
| Novo Nordisk | 24 | $340 |
| Teva Pharmaceuticals USA, Inc. | 26 | $332 |
| Amgen | 18 | $281 |
| Pfizer | 25 | $225 |
| GSK | 10 | $167 |
| Bayer | 3 | $118 |
| UCB, Inc. | 2 | $70 |
| Lilly USA, LLC | 4 | $70 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Edwards Lifesciences | 1 | $27 |
| Avanir Pharmaceuticals, Inc. | 1 | $22 |
| Merck | 1 | $20 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| Novartis | 1 | $17 |
| AstraZeneca | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$22,507
- NURTEC ODT$6,842
- QULIPTA$5,088
How this compares
$34,767 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 19 | $1,017 |
| Buspirone Hcl | 23 | $399 |
| Gabapentin | 12 | $342 |
| Triamcinolone Acetonide | 14 | $156 |
| Lidocaine HclLidocaine Hcl/Pf | 12 | $64 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Pittsburgh
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
- Nicole WaetzmanStrafford$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.